Focus on managing progress toward IDE application cuz nothing else matters at this point. Cutting JHU vet school a check to execute a contract without regular hands on supervision and oversight isn't management; it's neglect when entire future of RDGL rests on outcome. And all the IsoPet tweets in the world can't compensate for failure on getting Radiogel to human trials.